Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice
- PMID: 24576061
- PMCID: PMC3940255
- DOI: 10.1186/1471-244X-14-58
Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice
Abstract
Background: While various guidelines on the treatment of bipolar disorder have been published over the last decades, adherence to guidelines has been reported to be low. In this article we describe the protocol of a nationwide, multicenter, longitudinal, non-intervention study on the treatment of bipolar disorder in the Netherlands. Study aims are to provide information on the nature and content of outpatient treatment of bipolar disorder, to determine to what extent treatment is in concordance with the Dutch guideline for the treatment of bipolar disorder (2008), and to investigate the relationship of guideline concordance with symptomatic and functional outcome.
Methods/design: Between December 2009 and February 2010, all psychiatrists registered as member of the Dutch Psychiatric Association received a questionnaire with questions about their treatment setting, and whether they would be willing to participate in further research. Psychiatrists treating adult outpatients with bipolar disorder were invited to participate. Consenting psychiatrist subsequently approached all their patients with bipolar disorder. The study is performed with written patient and caregiver surveys at baseline and after 12 months, including data on demographics, illness characteristics, organization of care, treatments received, symptomatic and functional outcome, quality of life, and burden of care for informal caregivers.
Discussion: This study will provide information on the naturalistic treatment of bipolar disorder in the Netherlands, as well as degree of concordance of this treatment with the Dutch guideline, and its relationship with symptomatic and functional outcome. Limitations of a survey-based study are discussed.
Similar articles
-
A nationwide study on concordance with multimodal treatment guidelines in bipolar disorder.Int J Bipolar Disord. 2018 Oct 20;6(1):22. doi: 10.1186/s40345-018-0130-z. Int J Bipolar Disord. 2018. PMID: 30341458 Free PMC article.
-
Collaborative care for patients with bipolar disorder: a randomised controlled trial.BMC Psychiatry. 2011 Aug 17;11:133. doi: 10.1186/1471-244X-11-133. BMC Psychiatry. 2011. PMID: 21849078 Free PMC article. Clinical Trial.
-
Guideline concordance and outcome in long-term naturalistic treatment of bipolar disorder - a one-year longitudinal study using latent change models.J Affect Disord. 2021 Mar 15;283:395-401. doi: 10.1016/j.jad.2020.12.106. Epub 2020 Dec 29. J Affect Disord. 2021. PMID: 33581465
-
[Methodological approach to inter "guideline" variability in the management of bipolar disorders].Encephale. 2012 Apr;38(2):126-32. doi: 10.1016/j.encep.2011.07.004. Epub 2011 Aug 31. Encephale. 2012. PMID: 22516270 Review. French.
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
Cited by
-
A nationwide study on concordance with multimodal treatment guidelines in bipolar disorder.Int J Bipolar Disord. 2018 Oct 20;6(1):22. doi: 10.1186/s40345-018-0130-z. Int J Bipolar Disord. 2018. PMID: 30341458 Free PMC article.
-
Shared decision-making in the treatment of bipolar disorder: findings from a nationwide naturalistic cohort study in everyday clinical practice.Soc Psychiatry Psychiatr Epidemiol. 2025 Jun;60(6):1489-1497. doi: 10.1007/s00127-024-02761-8. Epub 2024 Oct 8. Soc Psychiatry Psychiatr Epidemiol. 2025. PMID: 39377952
-
Evidence of lithium underuse in bipolar disorder: analysis of lithium and antipsychotic consumption, prediction of future trends, regional disparities and indicators of rational and inappropriate use in Europe.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 28. doi: 10.1007/s00210-025-04389-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40580313
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical